• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.63% Nasdaq Up0.66%

    Generex Biotechnology Corp. (GNBT)

    -Other OTC
    0.01 Up 0.00(2.94%) 1:47PM EST
    ProfileGet Profile for:
    Generex Biotechnology Corp.
    555 Richmond Street West
    Suite 604
    Toronto, ON M5V 3B1
    Canada - Map
    Phone: 416-364-2551
    Fax: 647-547-7104
    Website: http://www.generex.com

    Index Membership:N/A
    Industry:Drug Delivery
    Full Time Employees:8

    Business Summary 

    Generex Biotechnology Corporation, a development stage company, researches, develops, and commercializes drug delivery systems and technologies for metabolic and immunological diseases. The company primarily focuses on its proprietary technology for the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator. It develops Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity using RapidMist hand-held aerosol spray applicator for the treatment of Type 1 and Type 2 diabetes. The company also researches and develops immunomedicine technology and products for the treatment of breast, prostate, and ovarian cancers; melanoma; influenza; HIV; and autoimmune diseases, such as diabetes and multiple sclerosis. Its immunomedicine technology and products include immunotherapeutic vaccine AE37 that is under Phase II clinical trial for patients with HER-2/neu positive breast cancer and for patients with prostate cancer, as well as under Phase I clinical trial in patients with breast or ovarian cancer; and synthetic peptide vaccines for H5N1 avian influenza and H1N1 swine flu. Generex Biotechnology Corporation was founded in 1983 and is based in Toronto, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Generex Biotechnology Corp.

    Key Executives 
    Mr. Mark A. Fletcher Esq., 50
    Chief Exec. Officer, Pres, Gen. Counsel and Director
    Mr. Stephen Fellows CA, 49
    Chief Financial Officer and Principal Accounting Officer
    Dr. David A. Brusegard Ph.D., 71
    Chief Operating Officer and Sec.
    Dr. Eric von Hofe Ph.D., 60
    VP, Director and Pres of Antigen Express, Inc
    Dr. Jaime A. Davidson M.D., FACP, FACE,
    Medical Director and Member of Scientific Advisory Board
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders